Neurology

Pharma News and Updates for Leo Pharma, GSK, Roche, Aldeyra, IASO Bio

Notizia - Recent Pharma, Healthcare and Biotech Happenings

Leo Pharma’s Hand Eczema Clinical Trial Updates; GSK’s PD-1 inhibitor Jemperli Approval; Roche Announces Phase III Result of Vabysmo; FDA Accepts NDA for Aldeyra’s reproxalap; RMAT and Fast Track Designations to IASO Bio’s CT103A; Orphan Drug Designation to Jubilant Therapeutics’s JBI-778

Leo Pharma Announces Positive Results of Phase III Hand Eczema Clinical Trial LEO Pharma A/S, a global leader in medical dermatology, announced that the DELTA 2 trial yielded positive results. DELTA 2 is the second of two pivotal phase III clinical trials involving delgocitinib cream, an investigational topical pan-Janus kinase (JAK) inhibitor, for the treatment of adults with moderate to severe chronic hand eczema (CHE). The trial's primary endpoint was met with a statistically significant improvement in CHE after 16 weeks of treatment with delgocitinib cream versus cream vehicle, and the treatment was well tolerated. When compared to subjects treated with crea...

Explore More...

recent-pharma-news-updates-for-bluerock-omniscient-neuspera-rivus

BlueRock secures FDA fast track; Omniscient rakes in $29M; Neuspera’s nerve implant gets a $65M boost Rivus’ therapy nabs $35M

Latest-pharma-happenings-for-hepion-nimbus-regeneron-bicycle-therapeutics

Hepion aces mid-stage study; Bicycle Therapeutics-Ionis collaboration; Nimbus raises $105M; Regeneron to support ISA Pharma

Neurovascular-Thrombectomy-Devices-Market

Insilico Medicine raises $255M; Sanofi & Translate Bio initiate trial; Medtronic gains expanded FDA approval; Blackstone, Cellex & Intellia form CAR-T startup

Spinal Stenosis Devices Market Size to Balloon Up Owing to Increasing Prevalence & Geriatric Population, as well as Medical Advancements

recent-pharma-news-updates-for-biogen-novo-nordisk-bluebird-bio

Biogen’s Alzheimer’s Drug; FDA approval to Novo Nordisk’s Wegovy; Bluebird’s Gene Therapy

Global Chronic Pain Associated With Painful Diabetic Neuropathy Market Landscape

recent-pharma-happenings-for-pfizer-abcellera-sarepta-eli-lilly

Pfizer hit by DMD delay & halts BCMA trials; Sarepta’s drug shows promise in Phase II; Human organ chips enable COVID-19 drug repurposing; AbCellera takes new antibody into clinic

Market & Competitive Assessment

Market Size & Forecast Assessment

Medical Devices

Market Research

Subscription

Competitive Intelligence

Business Consulting

Customized Solutions

Request for Proposal

Blog

Newsletter/Whitepaper

Infographics

Case Study

Events

Press Release

Analysis & Perspective

Neurology

Leo Pharma’s Hand Eczema Clinical Trial Updates; GSK’s PD-1 inhibitor Jemperli Approval; Roche Announces Phase III Result of Vabysmo; FDA Accepts NDA for Aldeyra’s reproxalap; RMAT and Fast Track Designations to IASO Bio’s CT103A; Orphan Drug Designation to Jubilant Therapeutics’s JBI-778

BlueRock secures FDA fast track; Omniscient rakes in $29M; Neuspera’s nerve implant gets a $65M boost Rivus’ therapy nabs $35M

Hepion aces mid-stage study; Bicycle Therapeutics-Ionis collaboration; Nimbus raises $105M; Regeneron to support ISA Pharma

Neurovascular Thrombectomy Devices Market

Vagus Nerve Stimulators Market Outlook

Wearable Devices: Weighing the Potential Benefits and Pitfalls of the Innovative Wearable Products

Insilico Medicine raises $255M; Sanofi & Translate Bio initiate trial; Medtronic gains expanded FDA approval; Blackstone, Cellex & Intellia form CAR-T startup

Does the use of Assistive Technologies in Autism Spectrum Disorder Payoff?

Horizon/ Arrowhead Deal; Dr Reddy’s Lab’s Drug US Launch; Targovax’s ONCOS-102; RedHill’s Oral Opaganib in COVID-19

More Views & Analysis

Mallinckrodt earns FDA nod for skin therapy; RayzeBio secures $108M; VectorY raises $38M; Umoja banks $210M

Eclipse, Medtronic, Aethlon, Cognoa, ObvioHealth, and others Continue to Veer MedTech Market Forward

Medical Devices Market Blooms as the Key MedTech Companies Continue to Bring-In Innovation

Spinal Stenosis Devices Market Size to Balloon Up Owing to Increasing Prevalence & Geriatric Population, as well as Medical Advancements

Biogen’s Alzheimer’s Drug; FDA approval to Novo Nordisk’s Wegovy; Bluebird’s Gene Therapy

Global Chronic Pain Associated With Painful Diabetic Neuropathy Market Landscape

Pfizer hit by DMD delay & halts BCMA trials; Sarepta’s drug shows promise in Phase II; Human organ chips enable COVID-19 drug repurposing; AbCellera takes new antibody into clinic

MedTech Industry Roars Back as FDA Approvals Soar

Subscribe to our Updates

Daily

Weekly

Monthly